Where Science Meets Recovery

Why People Relapse, and How to Stop It

A Whole-Person, Root-Cause Model for Addiction, Behavioral Health, Depression, and Anxiety.

With the Supporting Science

John Giordano, DHL, MAC, CAP

Root Cause Wellness · JC's Recovery Center

Research collaborations informed by the work of Kenneth Blum, PhD (Reward Deficiency Syndrome) and Deborah Mash, PhD (ibogaine)

Abstract

Relapse in addiction, compulsive behavior, depression, and anxiety is rarely caused by one thing, and it is rarely caused by weak character. Addictive behaviors, chronic stress, and the substances themselves compromise the body, the mind, and the spirit. When treatment addresses only the psychological layer and ignores the biology — and the spirit — underneath, people are set up to relapse, not because they lack willpower, but because an unresolved medical, nutritional, neurological, genetic, or spiritual driver keeps pulling them back. This paper lays out the major contributors to relapse and poor outcomes across four domains: the structure of care, lifestyle and self-regulation, medical and biological root causes, and a 24/7 digital continuing-care layer (Wingman for Recovery). Each contributor is paired with the current scientific evidence and an honest grade of how strong that evidence is. The unifying thesis is simple: sustained recovery requires treating the whole person — body, mind, and spirit — and getting to the root cause.

 

A Note on How the Evidence Is Graded

So this paper can stand up to clinical and academic scrutiny, every link below carries a plain-language grade:

• Strong — supported by randomized trials, large meta-analyses, or authoritative treatment guidelines.
• Moderate — supported by consistent studies or meta-analyses with meaningful limitations, or where treatment helps a defined subgroup.
• Emerging — biologically plausible and supported by association studies or mechanism, but not yet proven to cause the outcome. Worth screening for; not yet settled science.

Grading the weaker links honestly is a strength, not a weakness. It lets a clinician act on the strong evidence with confidence and investigate the emerging evidence responsibly.

For most of the last century, addiction and its companion conditions — depression and anxiety — were treated almost entirely as problems of the mind and the will. People who relapsed were told they hadn't worked the program hard enough. But decades of clinical experience and a large body of neuroscience now tell a different story. Addiction is a chronic, relapsing condition that changes brain structure and function, and those changes persist long after the last drink or dose [1]. At the same time, the biology that drives mood, craving, and self-control is shaped by hormones, blood sugar, the gut, the immune system, head trauma, heavy-metal exposure, and inherited differences in the brain's reward chemistry.

When any of these is broken and goes undiagnosed, the person carries an invisible headwind into recovery. They can do everything right behaviorally and still feel anxious, depressed, or driven to use — because the underlying machinery is still malfunctioning. The clinical philosophy behind this paper is that sustained treatment failure usually reflects a missed biological diagnosis, not a character flaw. The answer is to address the whole person — psychological, social, nutritional, hormonal, neurological, genetic, and spiritual — and to keep working the problem until the root cause is found and corrected.

 

2.1  Length of Stay: The 60–90 Day Threshold and Brain Healing

The brain needs time to heal, and the longer a person stays away from substances and addictive behaviors, the more that recovery consolidates and the stronger the foundation becomes. This is not just clinical folklore. The National Institute on Drug Abuse concluded, after decades of research, that for residential or outpatient treatment, participation of fewer than 90 days is of limited effectiveness, and that longer treatment is recommended to maintain positive outcomes; the threshold of significant improvement is reached at roughly three months in treatment [1]. Programs of 90 days or longer are consistently associated with higher rates of sustained abstinence than 30-day programs, and extended care of six to twelve months improves outcomes further [1, 2]. A 60- to 90-day inpatient stay gives the nervous system time to begin normalizing and gives the person time to practice new habits before returning to a high-risk environment. (One honest caveat from the literature: longer programs also see more dropout, so retention strategies matter as much as length itself [2].)

Strength of evidence: Strong — NIDA guidelines and consistent outcome data support the 90-day threshold; the '60–90 day' inpatient window is a reasonable, evidence-aligned target.

2.2  Family Involvement

Addiction and depression happen inside a family system, and they damage it. NIDA lists treatment of the whole person — including family therapy — as a core principle of effective care [1]. Involving family improves engagement and retention, repairs the relationships that either support or sabotage recovery, and gives the household the tools to stop unintentionally enabling relapse. Family members also carry their own trauma and stress from years of living with the illness, which is why aftercare must serve the family as well as the client.

Strength of evidence: Strong — Family involvement is an established principle of effective treatment and a consistent predictor of engagement and better outcomes.

2.3  Continuing Care and Aftercare for at Least One Year

Because addiction behaves like a chronic illness, a single episode of acute treatment is rarely enough — patients typically need long-term or repeated care, and continuing care is where lasting recovery is won or lost [1]. Relapse rates are highest in the first year, so structured aftercare should extend for at least twelve months for both the client and the family. Longer, more actively monitored continuing care produces better results than brief, passive aftercare. This is the rationale for a year-long recovery-management model rather than a 30-day fix.

Strength of evidence: Strong — Continuing-care research strongly supports extended, active aftercare; one year is a well-justified minimum.

2.4  Mutual-Help and Support Groups

Regular attendance at mutual-help groups is one of the most cost-effective recovery supports available. The 2020 Cochrane review of Alcoholics Anonymous and Twelve-Step Facilitation — 27 studies and more than 10,000 participants — found that manualized AA/TSF interventions were at least as effective as, and for continuous abstinence often superior to, other established treatments such as cognitive-behavioral therapy, while producing substantial healthcare cost savings [3]. Groups work by mobilizing many of the same mechanisms as professional treatment: coping skills, self-efficacy, motivation, reduced craving, and, above all, a healthier social network.

Strength of evidence: Strong — High-quality Cochrane evidence supports mutual-help participation for abstinence and cost savings.

2.5  Therapy and Complex Trauma

When it is affordable and available, individual therapy — with focused work on complex trauma and abuse — addresses one of the most powerful engines of relapse. The landmark Adverse Childhood Experiences (ACE) study established a strong, graded, dose-response relationship: the more childhood trauma a person carried, the higher their risk of alcohol and drug use disorders, depression, and suicide attempts in adulthood [4]. Trauma is not background noise in addiction; it is frequently the root. Resolving it (with appropriate pacing and stabilization) removes a driver that no amount of relapse-prevention coaching can outrun.

Strength of evidence: Strong — The ACE literature robustly links childhood trauma to later addiction and mood disorders; trauma-focused therapy is well established.

 

3.1  Nutrition, Blood Sugar, and Homeostasis

Eating whole foods and cutting sugar and ultra-processed products is not a cosmetic add-on; it changes brain chemistry. In a 2024 umbrella review in the BMJ, drawing on data from more than nine million people, higher consumption of ultra-processed foods was consistently linked to greater risk of anxiety and depression, among other harms [5]. A large observational study found that for every 10% increase in ultra-processed food as a share of daily calories, the risk of depression rose about 11% [6], and pooled analyses show ultra-processed diets associated with markedly higher odds of depressive and anxiety symptoms [7]. The proposed mechanisms — inflammation, oxidative stress, blood-sugar swings, and disruption of the gut microbiome — are exactly the systems that keep a recovering brain out of homeostasis. Anything that repeatedly throws the body out of balance is worth removing.

Strength of evidence: Moderate — Consistent, large observational evidence links ultra-processed diets to depression and anxiety; these are associations, and causation is still being confirmed.

3.2  Exercise

A structured exercise program releases stress and strengthens both body and mind. A 2023 overview of systematic reviews in the British Journal of Sports Medicine — 97 reviews covering more than 128,000 participants — found that physical activity produced medium-sized reductions in depression, anxiety, and psychological distress [8]. In people with substance use disorders specifically, a meta-analysis found that exercise significantly reduced anxiety and depression and improved cognitive function, with the largest benefits from sustained aerobic training [9]. Exercise is one of the few interventions that simultaneously improves mood, sleep, stress reactivity, and physical health.

Strength of evidence: Strong — Umbrella-level evidence supports exercise for depression and anxiety, including in addiction populations.

3.3  Meditation and Prayer

Practices that center a person — meditation and prayer — help regulate the stress response. A 47-trial meta-analysis in JAMA Internal Medicine found moderate evidence that mindfulness-meditation programs improve anxiety, depression, and pain [10]. The honest boundary here is that meditation was not shown to outperform other active treatments such as exercise or medication — it is a valuable complement, not a replacement. Prayer and spiritual practice, meanwhile, are consistently associated in observational research with better coping and recovery outcomes, and they are woven into the mutual-help traditions that the Cochrane evidence supports.

Strength of evidence: Moderate — Moderate evidence for mindfulness on anxiety/depression; spirituality's role is supported observationally and as part of mutual-help.

The heart of the whole-person model. A thorough medical work-up can uncover treatable drivers of depression, anxiety, and craving that are routinely missed. Below, each candidate root cause is paired with its evidence.

4.1  Blood-Sugar Dysregulation and Hypoglycemia

Unstable blood sugar can masquerade as a psychiatric problem. When glucose drops, the body releases adrenaline, producing tremor, palpitations, sweating, irritability, and a surge of anxiety that is physiologically indistinguishable from a panic attack, along with fatigue and low mood as the brain is starved of fuel. Reactive hypoglycemia and broader glycemic instability are therefore worth ruling out in anyone with prominent anxiety, mood swings, or cravings — especially given how closely diet, blood sugar, and the ultra-processed foods discussed above are linked.

Strength of evidence: Emerging — Mechanistically well understood and clinically recognized; large controlled trials tying reactive hypoglycemia to mood disorders are limited, so screen and correct rather than assume.

4.2  Thyroid Dysfunction

The thyroid sets the metabolic tempo of the brain, and when it runs low the result can look exactly like depression. A meta-analysis of 25 studies and roughly 348,000 participants found a moderate association between overt hypothyroidism and clinical depression, stronger in women [11]. The picture for subclinical (mild) hypothyroidism is more mixed — some analyses find raised depression risk mainly in younger patients, others find little effect — which is exactly why a full panel, not a single TSH, is needed. Undiagnosed low thyroid is a classic missed cause of treatment-resistant depression.

Strength of evidence: Moderate — Overt hypothyroidism is clearly linked to depression; subclinical disease is mixed. A full thyroid panel is warranted.

4.3  The Gut: Intestinal Permeability and H. pylori

The gut and brain are in constant two-way communication. When the intestinal barrier becomes leaky, bacterial products (such as lipopolysaccharide) cross into the bloodstream and trigger low-grade inflammation that reaches the brain. A 2025 systematic review and meta-analysis found that biomarkers of intestinal permeability and the inflammation it drives (zonulin, endotoxin antibodies, sCD14, I-FABP) were elevated in people with depressive symptoms compared with controls [12]. Separately, a 2024 meta-analysis found Helicobacter pylori infection significantly associated with anxiety (odds ratio about 2.5); its link to depression was weaker and less consistent [13]. Treating an infection or a compromised gut barrier will not cure everyone, but in the right patient it removes a genuine inflammatory driver of mood symptoms.

Strength of evidence: Emerging — Gut–brain associations are consistent and mechanistically strong; H. pylori's tie to anxiety is solid, to depression less so. Associations, not proven cause.

4.4  Hormones: Testosterone

Testosterone is a neuroactive hormone that influences mood, motivation, and serotonin signaling, and the relationship runs in both directions — both ends of the spectrum can cause trouble. On the low side, men with depression have lower testosterone on average, depression severity tracks inversely with free testosterone, and meta-analyses show that testosterone treatment reduces depressive symptoms in hypogonadal men, particularly at adequate doses [14, 15]. On the high side, supraphysiologic testosterone — most often from anabolic-androgenic steroid use — is associated with irritability, aggression, mood instability, and depression, especially during withdrawal. A level sitting at the far end of the reference range can still be symptomatic for a given individual. Testosterone is not a routine antidepressant, but measuring it is essential when depression and anxiety are unexplained.

Strength of evidence: Moderate — Low testosterone is linked to depression and responds to treatment in hypogonadal men; supraphysiologic/steroid-driven excess is linked to mood disturbance.

4.5  Heavy-Metal Toxicity

Toxic metals interfere directly with how neurons signal. Lead, mercury, cadmium, and arsenic disrupt neurotransmission — including dopamine and serotonin pathways — and drive oxidative stress and neuroinflammation, effects linked in the literature to cognitive deficits, depression, and anxiety [16, 17]. This matters because the effect is on the wiring itself: a person can do all the psychological work in the world while a neurotoxic burden quietly keeps their neurotransmitters out of balance. The evidence is strongest at meaningful exposure levels, so testing is how you separate a real contributor from a red herring.

Strength of evidence: Moderate — Neurotoxic mechanisms are well established and exposure is linked to mood and cognitive effects; individual low-level causation requires testing to confirm.

4.6  Closed Head Injury and Traumatic Brain Injury

This population is full of head injuries — car accidents, falls off ladders, fights, falls while intoxicated — and those injuries change behavior. In the first year after a traumatic brain injury, up to 77% of patients receive a psychiatric diagnosis, most commonly mood, anxiety, and substance-use disorders [18]. A large meta-analysis found roughly 27% of TBI patients are clinically diagnosed with depression [19]. Injury to frontal circuits produces impulsivity, irritability, affective instability, and aggression — the exact behavioral profile that fuels relapse — and TBI and substance use reinforce each other. A history of head injury should be actively sought, because it reframes 'behavioral problems' as a consequence of brain injury.

Strength of evidence: Strong — TBI is robustly linked to depression, anxiety, and behavioral dysregulation, and is highly prevalent in this population.

4.7  Genetics: DRD2 and Reward Deficiency Syndrome

Some people are born with a reward system that is harder to satisfy. In 1990, Kenneth Blum and Ernest Noble reported an association between the A1 allele of the dopamine D2 receptor gene (DRD2) and severe alcoholism [20], and Blum went on to define Reward Deficiency Syndrome (RDS) — a state of low dopamine function (hypodopaminergia) that predisposes to a whole family of addictive, compulsive, and impulsive behaviors [21]. In candor, the DRD2 association was historically controversial and early replication was mixed; more recently, a meta-analysis of 62 studies found a significant association between the DRD2 variant and alcohol use disorder [21]. The practical value of the RDS framework is that it reframes addiction as, in part, an inherited neurochemical deficit — which points toward restoring dopamine balance rather than blaming the patient.

Strength of evidence: Moderate — Historically debated but supported by recent meta-analysis; RDS is a well-developed framework (Blum) with growing, if still contested, genetic support.

4.8  The Vagus Nerve and Autonomic Balance

The vagus nerve is the main line of the parasympathetic 'rest-and-recover' system, and when it is out of balance, mood and anxiety suffer. Low vagal tone — measured non-invasively as reduced heart-rate variability — is repeatedly associated with depression, anxiety, PTSD, and poorer emotion regulation [22, 23]. Major depression is increasingly understood as a state of autonomic imbalance, with the sympathetic 'fight-or-flight' system overactive and vagal activity blunted; vagus-nerve stimulation is even an approved treatment for treatment-resistant depression [22]. Vagal tone is also modifiable — through breathing, exercise, and other practices — which makes it both a marker and a target.

Strength of evidence: Emerging — Consistent associations between low vagal tone/HRV and mood and anxiety disorders; VNS is approved for resistant depression. A promising, partly modifiable target.

4.9  Sleep Apnea

Obstructive sleep apnea (OSA) may be the single most overlooked cause of depression and anxiety that simply will not lift. Night after night the airway collapses, cutting off oxygen and shattering sleep — producing intermittent hypoxia, oxidative stress, systemic inflammation, and a surge of sympathetic 'fight-or-flight' activity. The brain never gets the restorative sleep it needs, and the result looks exactly like depression: fatigue, low mood, poor concentration, irritability, and anxiety.

Critically, untreated OSA is a leading reason antidepressants and therapy stop working — it is a genuine driver of treatment resistance. In one study of patients with chronic treatment-resistant depression, 64% screened at high risk for sleep apnea [28] — meaning that for a large share of people whose depression 'won't respond,' the real problem was never being treated. When OSA is identified and corrected, mood often improves: in the large SAVE randomized trial of more than 2,400 patients, CPAP therapy reduced depression and anxiety symptoms within months [29]. No amount of medication adjustment can outrun an airway that closes every night.

Beyond mood, sleep apnea quietly erodes physical health. It is an independent risk factor for high blood pressure (including resistant hypertension), stroke, coronary artery disease, heart failure, type 2 diabetes, and cognitive decline [30]. This is why a few screening questions about snoring, witnessed pauses in breathing, and daytime sleepiness — followed by a sleep study when warranted — belong in every thorough work-up, especially when depression has resisted treatment.

Strength of evidence: Strong — OSA is robustly linked to depression, anxiety, treatment resistance, and major cardiovascular and metabolic disease; CPAP improves mood in trials, though the size of that mood benefit varies across studies.

The biological drivers above cannot be corrected until they are measured. A comprehensive, clinician-directed work-up — individualized to the patient — should consider:

• Full thyroid panel — TSH, free T4, free T3, and thyroid antibodies (not TSH alone).
• Glucose and metabolic markers — fasting glucose, HbA1c, and fasting insulin; consider a glucose-tolerance assessment where reactive hypoglycemia is suspected.
• Gut and inflammation — H. pylori testing, markers of intestinal permeability/inflammation (e.g., calprotectin, zonulin), and hs-CRP.
• Hormone panel — total and free testosterone (and a fuller sex-hormone/adrenal panel as indicated).
• Heavy-metal testing — blood and/or urine screening for lead, mercury, cadmium, and arsenic.
• Micronutrient and nutrient-deficiency testing — to identify deficiencies (e.g., B-vitamins, vitamin D, magnesium, zinc, iron) that affect mood and neurotransmitter synthesis.
• Methylation testing — MTHFR status, homocysteine, B12 and folate — to assess whether the person is actually absorbing and using key nutrients.
• Autonomic assessment — heart-rate-variability measurement as a window on vagal tone.
• Sleep assessment — screening for obstructive sleep apnea (e.g., STOP-BANG or Berlin questionnaire) and a formal sleep study when indicated, especially in anyone with treatment-resistant depression, loud snoring, or daytime sleepiness.

The point is not to run every test on every patient, but to keep investigating until the root cause is found. Any one of these, left undiagnosed, can drive depression, anxiety, and cravings — and derail otherwise excellent treatment.

Everything above describes what recovery requires. Wingman for Recovery is the tool that delivers it in the moments that matter — between sessions, after hours, and in the exact instant a person feels like using or feels the depression closing in. It is a digital companion the client can talk to any time, that responds with nonjudgmental support and gives real solutions for the abnormalities and behaviors that drive relapse.

 

6.1  Why 24/7 Access Is Non-Negotiable

Craving and crisis do not keep office hours. The highest-risk moments — 2 a.m., a fight with a partner, a wave of hopelessness — fall outside every clinic's schedule. A support that is available around the clock meets the person at the point of risk rather than at the next appointment. This is the single feature that turns good intentions into a caught relapse.

 

6.2  The Science Behind a Digital Recovery Companion

This is not an untested idea — it is one of the better-validated innovations in addiction care. In a randomized clinical trial published in JAMA Psychiatry, patients leaving residential alcohol treatment who were given a smartphone recovery app (A-CHESS) reported significantly fewer risky drinking days than those receiving usual care — roughly half as many — and were more likely to stay abstinent across a full year of follow-up [24]. A-CHESS worked by providing exactly what Wingman provides: continuous, on-demand support, coping tools, monitoring, and connection. Wingman applies this evidence base — and decades of clinical knowledge from treating addiction, depression, and anxiety — in one always-available companion.

 

6.3  What Wingman Does

• In-the-moment support — a nonjudgmental companion to talk to when the urge to use or the weight of depression hits, day or night.
• Homework and things to work on — the between-session assignments that make therapy stick, held in one place.
• Goal-setting and wellness programs — structured targets plus nutrition, exercise, and stress-regulation protocols drawn from the evidence in this paper.
• Aftercare for the client and the family — the year-long continuing-care layer, extended to the people who live alongside recovery.
• Psychoeducation on complex trauma — clear explanations of what complex trauma is and how it shapes our lives, so clients understand their own patterns.
• Solutions, not just sympathy — concrete strategies for the specific biological and behavioral drivers of relapse identified in the work-up.

 

6.4  Tracking to Improve Outcomes

What gets measured gets managed. Measurement-based care — routinely tracking symptoms with validated tools and adjusting the plan accordingly — has been shown across randomized trials and meta-analyses to improve outcomes, catch deterioration early, and increase engagement compared with usual care [25]. By tracking mood, cravings, sleep, activity, and progress toward goals, Wingman turns recovery from a guessing game into a data-guided process, and gives the clinical team an early warning long before a lapse becomes a full relapse.

Strength of evidence: Strong — A randomized trial supports a smartphone recovery companion for reducing risky drinking; measurement-based care is well supported for improving outcomes.

Addiction and its companions do not only compromise the body and the mind — they compromise the soul. Years of active addiction, depression, and anxiety hollow out a person's sense of meaning, connection, and purpose, leaving a spiritual emptiness that the drugs, alcohol, and compulsive behaviors were often trying to fill in the first place. For this reason, spirituality — not religion — is usually the foundation on which lasting treatment is built.

The distinction matters. Religion refers to a specific tradition, doctrine, and institution; spirituality is broader and more personal — a sense of connection to others and to something greater than oneself, and a renewed sense of meaning and purpose. A person can be deeply spiritual without being religious, which is precisely why a spiritual foundation reaches people a religious one may not. And this is not merely philosophy. In a national U.S. study of people recovering from alcohol and drug problems, spirituality — but notably not religion — was associated with aiding recovery [26]. In rigorous analyses of how Alcoholics Anonymous actually works, increases in spirituality have been identified as a principal mechanism of behavior change, mediating its effect on drinking outcomes [27]. The mutual-help traditions supported by the Cochrane evidence cited earlier are themselves spiritual — not religious — movements that restore meaning, connection, and hope.

Understood this way, spirituality is not an add-on tacked onto the end of treatment; it is the ground the rest of the work stands on. When a person recovers a sense of meaning and connection, the medical corrections, the therapy, the exercise, and the daily practices all have something to serve. Healing the body and the mind gives a person the capacity to recover; healing the spirit gives them a reason to.

Strength of evidence: Moderate — Spirituality (distinct from religion) is consistently associated with recovery and is an identified mechanism of change in mutual-help; the evidence is largely observational and mediational rather than from standalone randomized trials.

People relapse for reasons that are far more diverse — and far more treatable — than a failure of willpower. Some reasons live in the structure of care: too little time in treatment, no family involvement, thin aftercare, no support group, unaddressed trauma. Some live in daily habits: a diet that inflames the brain, no exercise, no practice that quiets the stress response. And many live in the body itself: unstable blood sugar, a sluggish thyroid, a leaky gut, an infection, a hormone at the wrong level, a heavy-metal burden, an old head injury, an inherited reward deficit, an autonomic nervous system stuck in overdrive.

Addiction, depression, and anxiety compromise the body, the mind, and the spirit, so recovery has to repair all three. That means treating the whole person and refusing to stop until the root cause is found. It means extending care beyond the clinic walls — through a 24/7 companion like Wingman for Recovery — so that support, solutions, and tracking are there in the exact moment a person needs them. And it means building the entire effort on a spiritual foundation, because in the end a person needs not only the capacity to recover but a reason to. This is what it looks like where science meets recovery.

1. National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). Bethesda, MD: NIDA; 2018.
2. McKay JR, and related outcome literature summarized in: Greenfield L, et al. Length of stay and treatment outcomes in substance use disorder; see also NIDA (ref. 1) on treatment duration and retention.
3. Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. 2020;(3):CD012880.
4. Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine. 1998;14(4):245–258.
5. Lane MM, Gamage E, Du S, et al. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ. 2024;384:e077310.
6. Samuthpongtorn C, Nguyen LH, Okereke OI, et al. Consumption of ultra-processed food and risk of depression. JAMA Network Open. 2023;6(9):e2334770.
7. Lane MM, Gamage E, Travica N, et al. Ultra-processed food consumption and mental health: a systematic review and meta-analysis of observational studies. Nutrients. 2022;14(13):2568.
8. Singh B, Olds T, Curtis R, et al. Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. British Journal of Sports Medicine. 2023;57(18):1203–1209.
9. Meta-analysis of physical exercise on emotional and cognitive levels in patients with substance use disorder. Frontiers in Psychiatry / Public Health. 2024. (Aerobic exercise ≥12 weeks reduced anxiety and depression and improved cognition.)
10. Goyal M, Singh S, Sibinga EMS, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine. 2014;174(3):357–368.
11. Bode H, Ivens B, Bschor T, et al. Association of hypothyroidism and clinical depression: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78(12):1375–1383.
12. Morena D, Lippi M, Scopetti M, et al. Leaky gut biomarkers as predictors of depression and suicidal risk: a systematic review and meta-analysis. Diagnostics. 2025;15(13):1683.
13. Li X, Ren F, et al. Association of Helicobacter pylori infection with depression and anxiety: a systematic review and meta-analysis. International Journal of Clinical Practice. 2024;2024:9247586.
14. Walther A, Breidenstein J, Miller R. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76(1):31–40.
15. Zitzmann M, et al. The association of hypogonadism with depression and its treatments. Frontiers in Endocrinology. 2023;14:1198437.
16. Zheng X, et al. Interactions between cadmium, lead, mercury, and arsenic and depression: a molecular mechanism review. Journal of Affective Disorders. 2023;332:227–239.
17. Pyatha S, Kim H, Lee D, Kim K. Association of heavy metal exposure with neurotoxicity and mood/cognitive disorders: mechanisms and evidence (narrative review). 2023.
18. Alway Y, Gould KR, McKenzie DP, et al. Mental health consequences of traumatic brain injury (5-year follow-up); see also review: Mental health consequences of traumatic brain injury. Biological Psychiatry. 2022.
19. Osborn AJ, Mathias JL, Fairweather-Schmidt AK. Prevalence of depression following traumatic brain injury: meta-analytic findings (~27% clinically diagnosed).
20. Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 1990;263(15):2055–2060.
21. Blum K, et al. Evidence for the DRD2 gene as a determinant of Reward Deficiency Syndrome (RDS); GWAS and meta-analytic update (62-study meta-analysis of DRD2 rs1800497 and alcohol use disorder). Psychology Research and Behavior Management. 2023;16:4287–4302.
22. Thayer JF, Åhs F, Fredrikson M, et al., and Porges SW (polyvagal theory); reviews of heart-rate variability and vagal tone as markers of depression, anxiety, and emotion dysregulation.
23. Koenig J, et al. Vagally mediated heart rate variability in mood and anxiety disorders (meta-analytic and review evidence).
24. Gustafson DH, McTavish FM, Chih M-Y, et al. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry. 2014;71(5):566–572.
25. Fortney JC, Unützer J, Wrenn G, et al., and subsequent meta-analyses. The efficacy of measurement-based care for depressive disorders: systematic reviews and randomized controlled trials.
26. Kelly JF, et al. The role of spirituality and religiousness in aiding recovery from alcohol and other drug problems: an investigation in a national U.S. sample. 2021. (Key finding: spirituality, but not religion, was associated with aiding recovery, particularly among those with prior treatment or 12-step histories.)
27. Kelly JF, Stout RL, Magill M, Tonigan JS, Pagano ME. Spirituality in recovery: a lagged mediational analysis of Alcoholics Anonymous' principal theoretical mechanism of behavior change. Alcoholism: Clinical and Experimental Research. 2011;35(3):454–463.
28. Study of obstructive sleep apnea risk in chronic treatment-resistant depression: 64% of cTRD patients screened at high risk for OSA (Berlin questionnaire), with elevated rates of hypertension, diabetes, and obesity. International Journal of Psychiatry in Behavioral Sciences. 2018.
29. Zheng D, Xu Y, You S, et al. Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the SAVE randomised trial and meta-analysis. eClinicalMedicine (The Lancet). 2019;11:89–96.
30. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56–e67.

Prepared as a working evidence brief for Root Cause Wellness. Evidence grades reflect the state of the literature at the time of writing and are intended to guide clinical judgment, not replace it.